Clinical Trials Browser

Small Cell Lung Carcinoma Extensive Disease × durvalumab × Thoracic × Clear all

NCT04712903 2025-01-07

CANTABRICO

Phase 3 Completed

101 enrolled 47 charts

Small Cell Lung Carcinoma Extensive Disease

NCT04449861 2024-11-27

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

Phase 3 Completed

166 enrolled 20 charts

Small Cell Lung Carcinoma Extensive Disease